[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Chronic Idiopathic Constipation Drugs-China Market Status and Trend Report 2013-2023

May 2018 | 150 pages | ID: C3A2845EE20MEN
MIReports Co., Limited

US$ 2,980.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Summary

Chronic Idiopathic Constipation Drugs-China Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Chronic Idiopathic Constipation Drugs industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

Whole China and Regional Market Size of Chronic Idiopathic Constipation Drugs 2013-2017, and development forecast 2018-2023
Main market players of Chronic Idiopathic Constipation Drugs in China, with company and product introduction, position in the Chronic Idiopathic Constipation Drugs market
Market status and development trend of Chronic Idiopathic Constipation Drugs by types and applications
Cost and profit status of Chronic Idiopathic Constipation Drugs, and marketing status
Market growth drivers and challenges

The report segments the China Chronic Idiopathic Constipation Drugs market as:

China Chronic Idiopathic Constipation Drugs Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):

North China
Northeast China
East China
Central & South China
Southwest China
Northwest China

China Chronic Idiopathic Constipation Drugs Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):

Linaclotide
Lubiprostone
Other

China Chronic Idiopathic Constipation Drugs Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

China Chronic Idiopathic Constipation Drugs Market: Players Segment Analysis (Company and Product introduction, Chronic Idiopathic Constipation Drugs Sales Volume, Revenue, Price and Gross Margin):

Pfizer
Glaxosmithkline
Roche Holding AG
Sanofi
Bayer AG
Merck
Eli Lilly
Allergens
Chugai Pharmaceutical
Ferring International Center S.A
Synergy Pharmaceuticals
Salix Pharmaceuticals Ltd
Sucampo Pharmaceuticals Inc
Ironwood Pharmaceuticals Inc
Valeant Pharmaceuticals International
Daiichi Sankyo
Cosmo Pharmaceuticals SA
Progenics Pharmaceuticals Inc
Theravance Biopharma Inc

In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF CHRONIC IDIOPATHIC CONSTIPATION DRUGS

1.1 Definition of Chronic Idiopathic Constipation Drugs in This Report
1.2 Commercial Types of Chronic Idiopathic Constipation Drugs
  1.2.1 Linaclotide
  1.2.2 Lubiprostone
  1.2.3 Other
1.3 Downstream Application of Chronic Idiopathic Constipation Drugs
  1.3.1 Hospital Pharmacies
  1.3.2 Retail Pharmacies
  1.3.3 Online Pharmacies
1.4 Development History of Chronic Idiopathic Constipation Drugs
1.5 Market Status and Trend of Chronic Idiopathic Constipation Drugs 2013-2023
  1.5.1 India Chronic Idiopathic Constipation Drugs Market Status and Trend 2013-2023
  1.5.2 Regional Chronic Idiopathic Constipation Drugs Market Status and Trend 2013-2023

CHAPTER 2 INDIA MARKET STATUS AND FORECAST BY REGIONS

2.1 Market Status of Chronic Idiopathic Constipation Drugs in India 2013-2017
2.2 Consumption Market of Chronic Idiopathic Constipation Drugs in India by Regions
  2.2.1 Consumption Volume of Chronic Idiopathic Constipation Drugs in India by Regions
  2.2.2 Revenue of Chronic Idiopathic Constipation Drugs in India by Regions
2.3 Market Analysis of Chronic Idiopathic Constipation Drugs in India by Regions
  2.3.1 Market Analysis of Chronic Idiopathic Constipation Drugs in North India 2013-2017
  2.3.2 Market Analysis of Chronic Idiopathic Constipation Drugs in Northeast India 2013-2017
  2.3.3 Market Analysis of Chronic Idiopathic Constipation Drugs in East India 2013-2017
  2.3.4 Market Analysis of Chronic Idiopathic Constipation Drugs in South India 2013-2017
  2.3.5 Market Analysis of Chronic Idiopathic Constipation Drugs in West India 2013-2017
2.4 Market Development Forecast of Chronic Idiopathic Constipation Drugs in India 2017-2023
  2.4.1 Market Development Forecast of Chronic Idiopathic Constipation Drugs in India 2017-2023
  2.4.2 Market Development Forecast of Chronic Idiopathic Constipation Drugs by Regions 2017-2023

CHAPTER 3 INDIA MARKET STATUS AND FORECAST BY TYPES

3.1 Whole India Market Status by Types
  3.1.1 Consumption Volume of Chronic Idiopathic Constipation Drugs in India by Types
  3.1.2 Revenue of Chronic Idiopathic Constipation Drugs in India by Types
3.2 India Market Status by Types in Major Countries
  3.2.1 Market Status by Types in North India
  3.2.2 Market Status by Types in Northeast India
  3.2.3 Market Status by Types in East India
  3.2.4 Market Status by Types in South India
  3.2.5 Market Status by Types in West India
3.3 Market Forecast of Chronic Idiopathic Constipation Drugs in India by Types

CHAPTER 4 INDIA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY

4.1 Demand Volume of Chronic Idiopathic Constipation Drugs in India by Downstream Industry
4.2 Demand Volume of Chronic Idiopathic Constipation Drugs by Downstream Industry in Major Countries
  4.2.1 Demand Volume of Chronic Idiopathic Constipation Drugs by Downstream Industry in North India
  4.2.2 Demand Volume of Chronic Idiopathic Constipation Drugs by Downstream Industry in Northeast India
  4.2.3 Demand Volume of Chronic Idiopathic Constipation Drugs by Downstream Industry in East India
  4.2.4 Demand Volume of Chronic Idiopathic Constipation Drugs by Downstream Industry in South India
  4.2.5 Demand Volume of Chronic Idiopathic Constipation Drugs by Downstream Industry in West India
4.3 Market Forecast of Chronic Idiopathic Constipation Drugs in India by Downstream Industry

CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF CHRONIC IDIOPATHIC CONSTIPATION DRUGS

5.1 India Economy Situation and Trend Overview
5.2 Chronic Idiopathic Constipation Drugs Downstream Industry Situation and Trend Overview

CHAPTER 6 CHRONIC IDIOPATHIC CONSTIPATION DRUGS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN INDIA

6.1 Sales Volume of Chronic Idiopathic Constipation Drugs in India by Major Players
6.2 Revenue of Chronic Idiopathic Constipation Drugs in India by Major Players
6.3 Basic Information of Chronic Idiopathic Constipation Drugs by Major Players
  6.3.1 Headquarters Location and Established Time of Chronic Idiopathic Constipation Drugs Major Players
  6.3.2 Employees and Revenue Level of Chronic Idiopathic Constipation Drugs Major Players
6.4 Market Competition News and Trend
  6.4.1 Merger, Consolidation or Acquisition News
  6.4.2 Investment or Disinvestment News
  6.4.3 New Product Development and Launch

CHAPTER 7 CHRONIC IDIOPATHIC CONSTIPATION DRUGS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA

7.1 Pfizer
  7.1.1 Company profile
  7.1.2 Representative Chronic Idiopathic Constipation Drugs Product
  7.1.3 Chronic Idiopathic Constipation Drugs Sales, Revenue, Price and Gross Margin of Pfizer
7.2 Glaxosmithkline
  7.2.1 Company profile
  7.2.2 Representative Chronic Idiopathic Constipation Drugs Product
  7.2.3 Chronic Idiopathic Constipation Drugs Sales, Revenue, Price and Gross Margin of Glaxosmithkline
7.3 Roche Holding AG
  7.3.1 Company profile
  7.3.2 Representative Chronic Idiopathic Constipation Drugs Product
  7.3.3 Chronic Idiopathic Constipation Drugs Sales, Revenue, Price and Gross Margin of Roche Holding AG
7.4 Sanofi
  7.4.1 Company profile
  7.4.2 Representative Chronic Idiopathic Constipation Drugs Product
  7.4.3 Chronic Idiopathic Constipation Drugs Sales, Revenue, Price and Gross Margin of Sanofi
7.5 Bayer AG
  7.5.1 Company profile
  7.5.2 Representative Chronic Idiopathic Constipation Drugs Product
  7.5.3 Chronic Idiopathic Constipation Drugs Sales, Revenue, Price and Gross Margin of Bayer AG
7.6 Merck
  7.6.1 Company profile
  7.6.2 Representative Chronic Idiopathic Constipation Drugs Product
  7.6.3 Chronic Idiopathic Constipation Drugs Sales, Revenue, Price and Gross Margin of Merck
7.7 Eli Lilly
  7.7.1 Company profile
  7.7.2 Representative Chronic Idiopathic Constipation Drugs Product
  7.7.3 Chronic Idiopathic Constipation Drugs Sales, Revenue, Price and Gross Margin of Eli Lilly
7.8 Allergens
  7.8.1 Company profile
  7.8.2 Representative Chronic Idiopathic Constipation Drugs Product
  7.8.3 Chronic Idiopathic Constipation Drugs Sales, Revenue, Price and Gross Margin of Allergens
7.9 Chugai Pharmaceutical
  7.9.1 Company profile
  7.9.2 Representative Chronic Idiopathic Constipation Drugs Product
  7.9.3 Chronic Idiopathic Constipation Drugs Sales, Revenue, Price and Gross Margin of Chugai Pharmaceutical
7.10 Ferring International Center S.A
  7.10.1 Company profile
  7.10.2 Representative Chronic Idiopathic Constipation Drugs Product
  7.10.3 Chronic Idiopathic Constipation Drugs Sales, Revenue, Price and Gross Margin of Ferring International Center S.A
7.11 Synergy Pharmaceuticals
  7.11.1 Company profile
  7.11.2 Representative Chronic Idiopathic Constipation Drugs Product
  7.11.3 Chronic Idiopathic Constipation Drugs Sales, Revenue, Price and Gross Margin of Synergy Pharmaceuticals
7.12 Salix Pharmaceuticals Ltd
  7.12.1 Company profile
  7.12.2 Representative Chronic Idiopathic Constipation Drugs Product
  7.12.3 Chronic Idiopathic Constipation Drugs Sales, Revenue, Price and Gross Margin of Salix Pharmaceuticals Ltd
7.13 Sucampo Pharmaceuticals Inc
  7.13.1 Company profile
  7.13.2 Representative Chronic Idiopathic Constipation Drugs Product
  7.13.3 Chronic Idiopathic Constipation Drugs Sales, Revenue, Price and Gross Margin of Sucampo Pharmaceuticals Inc
7.14 Ironwood Pharmaceuticals Inc
  7.14.1 Company profile
  7.14.2 Representative Chronic Idiopathic Constipation Drugs Product
  7.14.3 Chronic Idiopathic Constipation Drugs Sales, Revenue, Price and Gross Margin of Ironwood Pharmaceuticals Inc
7.15 Valeant Pharmaceuticals International
  7.15.1 Company profile
  7.15.2 Representative Chronic Idiopathic Constipation Drugs Product
  7.15.3 Chronic Idiopathic Constipation Drugs Sales, Revenue, Price and Gross Margin of Valeant Pharmaceuticals International
7.16 Daiichi Sankyo
7.17 Cosmo Pharmaceuticals SA
7.18 Progenics Pharmaceuticals Inc
7.19 Theravance Biopharma Inc

CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF CHRONIC IDIOPATHIC CONSTIPATION DRUGS

8.1 Industry Chain of Chronic Idiopathic Constipation Drugs
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis

CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF CHRONIC IDIOPATHIC CONSTIPATION DRUGS

9.1 Cost Structure Analysis of Chronic Idiopathic Constipation Drugs
9.2 Raw Materials Cost Analysis of Chronic Idiopathic Constipation Drugs
9.3 Labor Cost Analysis of Chronic Idiopathic Constipation Drugs
9.4 Manufacturing Expenses Analysis of Chronic Idiopathic Constipation Drugs

CHAPTER 10 MARKETING STATUS ANALYSIS OF CHRONIC IDIOPATHIC CONSTIPATION DRUGS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

CHAPTER 11 REPORT CONCLUSION

CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE

12.1 Methodology/Research Approach
  12.1.1 Research Programs/Design
  12.1.2 Market Size Estimation
  12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
  12.2.1 Secondary Sources
  12.2.2 Primary Sources
12.3 Reference


More Publications